NCT05258422View on ClinicalTrials.gov

Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT)

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2031

Conditions
Ventricular TachycardiaArrhythmiaArrhythmic StormRadiation Toxicity
Interventions
RADIATION

stereotactic body radiotherapy, 20 Gy in 1 fraction

A single dose of focused radiation therapy of 20 Gy in 1 fraction to the PTV of the arrhythmogenic substrate

Trial Locations (1)

H4A3J1

Cedars Cancer Center, McGill University Health Centre, Montreal

All Listed Sponsors
lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER